Surmodics, Inc. (SRDX)
NASDAQ: SRDX · Real-Time Price · USD
27.52
-0.80 (-2.82%)
At close: Nov 4, 2025, 4:00 PM EST
27.50
-0.02 (-0.07%)
After-hours: Nov 4, 2025, 4:10 PM EST
Surmodics Market Cap
Surmodics has a market cap or net worth of $393.47 million as of November 4, 2025. Its market cap has decreased by -28.15% in one year.
Market Cap
393.47M
Enterprise Value
393.04M
1-Year Change
-28.15%
Ranking
Category
Stock Price
$27.52
Market Cap Chart
Since December 1, 1998, Surmodics's market cap has increased from $67.50M to $393.47M, an increase of 482.92%. That is a compound annual growth rate of 6.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 404.90M | -28.63% |
| Dec 31, 2024 | 567.30M | 10.24% |
| Dec 29, 2023 | 514.60M | 7.43% |
| Dec 30, 2022 | 479.00M | -28.45% |
| Dec 31, 2021 | 669.50M | 12.48% |
| Dec 31, 2020 | 595.20M | 6.04% |
| Dec 31, 2019 | 561.30M | -11.36% |
| Dec 31, 2018 | 633.20M | 72.63% |
| Dec 29, 2017 | 366.80M | 9.33% |
| Dec 30, 2016 | 335.50M | 27.86% |
| Dec 31, 2015 | 262.40M | -7.67% |
| Dec 31, 2014 | 284.20M | -15.16% |
| Dec 31, 2013 | 335.00M | 2.20% |
| Dec 31, 2012 | 327.80M | 27.55% |
| Dec 30, 2011 | 257.00M | 23.97% |
| Dec 31, 2010 | 207.30M | -47.64% |
| Dec 31, 2009 | 395.90M | -11.31% |
| Dec 31, 2008 | 446.40M | -54.99% |
| Dec 31, 2007 | 991.70M | 73.25% |
| Dec 29, 2006 | 572.40M | -16.56% |
| Dec 30, 2005 | 686.00M | 19.85% |
| Dec 31, 2004 | 572.40M | 38.03% |
| Dec 31, 2003 | 414.70M | -16.41% |
| Dec 31, 2002 | 496.10M | -18.92% |
| Dec 31, 2001 | 611.90M | 0.02% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 789.89B |
| Johnson & Johnson | 452.71B |
| AbbVie | 379.70B |
| UnitedHealth Group | 299.34B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.51B |